Financial Perspectives’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $148K | Sell |
191
-2
| -1% | -$1.53K | 0.04% | 196 |
|
|
2025
Q4 | $149K | Hold |
193
| – | – | 0.04% | 188 |
|
|
2025
Q3 | $109K | Hold |
193
| – | – | 0.03% | 223 |
|
|
2025
Q2 | $101K | Hold |
193
| – | – | 0.03% | 219 |
|
|
2025
Q1 | $122K | Hold |
193
| – | – | 0.04% | 192 |
|
|
2024
Q4 | $137K | Buy |
193
+19
| +11% | +$15.9K | 0.05% | 177 |
|
|
2024
Q3 | $183K | Hold |
174
| – | – | 0.06% | 146 |
|
|
2024
Q2 | $183K | Hold |
174
| – | – | 0.07% | 142 |
|
|
2024
Q1 | $167K | Hold |
174
| – | – | 0.06% | 151 |
|
|
2023
Q4 | $153K | Hold |
174
| – | – | 0.06% | 158 |
|
|
2023
Q3 | $143K | Hold |
174
| – | – | 0.07% | 153 |
|
|
2023
Q2 | $125K | Hold |
174
| – | – | 0.06% | 160 |
|
|
2023
Q1 | $143K | Hold |
174
| – | – | 0.07% | 147 |
|
|
2022
Q4 | $126K | Hold |
174
| – | – | 0.06% | 154 |
|
|
2022
Q3 | $120K | Hold |
174
| – | – | 0.07% | 155 |
|
|
2022
Q2 | $103K | Hold |
174
| – | – | 0.06% | 168 |
|
|
2022
Q1 | $122K | Hold |
174
| – | – | 0.06% | 169 |
|
|
2021
Q4 | $110K | Hold |
174
| – | – | 0.05% | 166 |
|
|
2021
Q3 | $105K | Hold |
174
| – | – | 0.05% | 169 |
|
|
2021
Q2 | $97.2K | Sell |
174
-82,152
| -100% | -$41.6M | 0.05% | 189 |
|
|
2021
Q1 | $174K | Buy |
82,326
+82,152
| +47,214% | +$40M | 0.01% | 417 |
|
|
2020
Q4 | $84.1K | Buy |
174
+94
| +118% | +$50.7K | 0.05% | 182 |
|
|
2020
Q3 | $44.8K | Buy |
80
+12
| +18% | +$7.28K | 0.03% | 209 |
|
|
2020
Q2 | $42.4K | Hold |
68
| – | – | 0.03% | 198 |
|
|
2020
Q1 | $33.2K | Buy |
+68
| New | +$28K | 0.03% | 194 |
|
Other funds holding REGN
VCM
N
